Edition:
India

Roche Holding AG (RHHBY.PK)

RHHBY.PK on OTC Markets Group

41.22USD
23 Nov 2020
Change (% chg)

$-0.46 (-1.09%)
Prev Close
$41.68
Open
$41.79
Day's High
$41.83
Day's Low
$41.16
Volume
1,491,871
Avg. Vol
1,070,447
52-wk High
$47.15
52-wk Low
$35.04

Summary

Name Age Since Current Position

Severin Schwan

53 2013 Chairman of the Corporate Executive Committee, Chief Executive Officer, Executive Director

Christoph Franz

59 2011 Non-Executive Independent Chairman of the Board

Fritz Gerber

90 2004 Honorary Chairman of the Board

Andre Hoffmann

62 Non-Executive Independent Vice Chairman of the Board

Alan Hippe

53 2011 Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer

Cristina Wilbur

53 2016 Member of the Corporate Executive Committee, Head Group Human Resources

Pascale Schmidt

2019 Chief Compliance Officer

Claudia Boeckstiegel

55 2020 Member of the Corporate Executive Committee, General Counsel

William Anderson

53 2019 Member of the Corporate Executive Committee, Chief Executive Officer Roche Pharmaceuticals

William Pao

53 2018 Member of the Enlarged Corporate Executive Committee, Head Roche Pharma Research & Early Development (pRED)

James Sabry

61 2018 Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering

Barbara Schaedler

58 2019 Member of the Enlarged Corporate Executive Committee, Head Group Communications

Thomas Schinecker

45 2019 Member of the Corporate Executive Committee, Chief Executive Officer Roche Diagnostics

Michael Varney

62 2015 Member of the Enlarged Corporate Executive Committee, Head Genentech Research & Early Development (gRED)

Per-Olof Attinger

60 2010 Secretary to the Corporate Executive Committee

Hans Clevers

63 2019 Director

Joerg Duschmale

36 2020 Director

Patrick Frost

52 2020 Director

Julie Brown

58 2016 Non-Executive Independent Director

Paul Bulcke

66 2011 Non-Executive Independent Director

Anita Hauser

51 2017 Non-Executive Independent Director

Richard Lifton

67 2015 Non-Executive Independent Director

Bernard Poussot

68 2015 Non-Executive Independent Director

Claudia Suessmuth Dyckerhoff

53 2016 Non-Executive Independent Director

Karl Mahler

Head of Investor Relations

Biographies

Name Description

Severin Schwan

Dr. Severin Schwan serves as Chairman of the Corporate Executive Committee, Chief Executive Officer, Executive Director of the Company. He was Chairman of the Corporate Executive Committee and Chief Executive Officer of Roche Holding AG from March 4, 2008. He was previously Chief Executive Officer of the Division Roche Diagnostics and Member of the Corporate Executive Committee at the Company from January 1, 2006. Between 1993 and 1995, he was a Trainee at Corporate Finance for Roche Basel. From 1995 until 1998, he was Head of Finance & Administration at Roche Brussels. From 1998 until 2000, Dr. Schwan was Head Finance & Informatics at Roche Grenzach, Germany and Member of the Executive Board of Roche Deutschland Holding GmbH. From 2000 until 2004, he was Head of Global Finance & Services at Roche Diagnostics, Basel. Since 2009, Dr. Schwan has been Member of the Board of Directors of Chugai Pharmaceuticals, Japan, and Member of the International Business Leaders Advisory Council for the Mayor of Shanghai (IBLAC). Dr. Schwan studied Economics at Universitaet Innsbruck, University of York and University of Oxford. He gained an Economics Degree from Innsbruck. He studied Law at Universitaet Innsbruck and gained a Law degree in 1991. Dr. Schwan then completed a Doctorate in Law at Universitaet Innsbruck in 1993 and Research studies at Universite Catholiques de Louvaine, Belgium.

Christoph Franz

Dr. Christoph Franz serves as Non-Executive Independent Chairman of the Board of the Company. He is Member of the Remuneration Committee and Chairman of the Presidium/Nomination Committee at the Company. He began his career in 1991 with Deutsche Lufthansa AG. In 1994 he joined Deutsche Bahn AG and acted as Member of the Executive Board and CEO of passenger transport division. In 2004 he became Chief Executive Officer of Swiss International Air Lines AG. In 2009 Dr. Franz became Member of the Executive Board of Deutsche Lufthansa AG and Deputy to the Executive Board Chairman and CEO Lufthansa Passenger Airlines. Since January 2011 he has been Chairman of the Executive Board and Chief Executive Officer of Deutsche Lufthansa AG. He holds a Doctorate degree (Dr. rer. pol.) from Technische Universitaet Darmstadt (Darmstadt University of Technology).

Fritz Gerber

Dr. Fritz Gerber serves as Honorary Chairman of the Board of the Company. Between 2001 and 2004, he additionally acted as Company's Member of the Board of Directors. From 1978 to 1997 Dr. Gerber occupied the position of Chairman of the Board at Roche Holding Ltd. and was also active as Chief Executive Officer between 1978 and 1997. Dr. Gerber has worked in the Federal Department of Economic Affairs, Bern (now SECO). In 1958, he joined "Zuerich" Insurance Company (now Zurich Financial Services), where he became General Manager in 1969 and Chairman of the Management Board in 1974. From 1977 until 1991, Dr. Gerber was Chairman of the Board of Directors and Chief Executive Officer and from 1991 until 1995, he was Non-Executive Chairman of the Board of Directors. Since 1995, he has been Honorary Chairman of Zurich Financial Services. From 1978 until 1997, he was Chairman of the Board of Directors and Chief Executive Officer of F. Hoffmann-La Roche & Co. Ltd. (now: Roche Holding Ltd.). From 1978 until 2001, Dr. Gerber was Chairman of the Board of Directors and from 2001 until 2004, he was Member of the Board of Directors and Honorary Chairman. He has also served as Member of the Board of I.C.I. Switzerland from 1967 until 1991, Alusuisse, Zuerich from 1977 until 1981, Credit Suisse, Zuerich, from 1978 until 1996, Nestle, Vevey (Deputy Chairman of the Board) from 1981 until 2001, IBM Corporation, Armonk from 1989 until 1996 and Bank Sal. Oppenheim jr., Zurich from 1997 until 2005. He served as Chairman of the Paul Sacher Foundation for contemporary music until April 2006, was Member of the Executive Committee of the Lucerne Music Festival until 2004 and Member of the Orchesterakademie des Philharmonischen Orchesters Berlin until 2004. Dr. Gerber has been Honorary Chairman of the Fritz Gerber Foundation. He studied at Universitaet Bern and graduated as Lawyer (LL.M) and was admitted to the bar. He is an Honorary Doctor of Natural Science of Universitaet Basel, Switzerland.

Andre Hoffmann

Mr. Andre S. Hoffmann serves as Non-Executive Independent Vice Chairman of the Board of the Company. He is representative of the shareholder group with pooled voting rights. He also acts as Member of the Presidium/Nomination Committee, Corporate Governance and Sustainability Committee, as well as Chairman of the Remuneration Committee of the Company. He joined the Company’s Board of Directors in 1996. From 1977 until 1978, he studied at Universite de Geneve and from 1979 until 1982 he studied at St. Gallen School. In 1990, he received a Master of Business Administration degree from Institut Europeen d’Administration des Affaires (INSEAD). From 1985 until 1989, he worked for James Capel and Co., where his latest position was Manager, European Mergers & Acquisitions. From 1991 until 1993, he worked for Nestle UK Ltd., where his latest position was Special Project Manager, Food division. Since 1994, he worked in Private Investment Activities. Since 2000, he has been Member of the Board of Givaudan Ltd., Member of the Board of Glyndebourne Productions Ltd., and Chairman of Nemadi Advisors Ltd. Since 2003, he has been Member of the Board of Brunswick Capital Ltd. and Chairman of Living Planet Fund Management Co. He has served as Vice President of WWF International, Treasurer of Fondation les Corbillettes pour l'Aide aux enfants handicapes mentaux, Member of the Executive Committee of IRP, Institut International de Recherche en Paraplegie, Founding Member of Stiftung Patronatskomitee Kunstmuseum Basel, Board Member of Roche Research Foundation, International Council Member of Tate Gallery, Chairman of the Board of Fondation Pro Valat, Vice Chairman of the Board of Fondation Sansouire, Board Member of Takh, Association pour le Cheval de Przewalski, President of FIBA, Fondation Internationale du Banc d'Arguin, among others.

Alan Hippe

Dr. Alan Hippe serves as Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer of the Company. Between 1993 and 1996 Dr. Hippe was Research Assistant and Teaching Assistant at the Universities of Mainz and Mannheim. In 1996 he joined AVECO Holding AG as Head of group controlling and IT systems. He served as Member of the Executive Board of Continental AG from 2002 to 2009. In April 2009 he was appointed Chief Financial Officer and Member of Executive Board of ThyssenKrupp AG.

Cristina Wilbur

Ms. Cristina A. Wilbur serves as Member of the Corporate Executive Committee, Head Group Human Resources of the Company. She holds Bachelor of Science degree in Accounting from California Polytechnic University. She served at EG&G as Human Resources and Payroll Manager and later as Human Resources Director. In 2001 she joined PerkinElmer Optoelectronics as Human Resources Director. In 2002 she joined Roche Diagnostics Corporation as Human Resources Director, where in 2006 she was appointed Vice-President, North America Region Human Resources and Communications. In 2010 she became Senior Vice-President and Global Head of Human Resources at Roche Diagnostics Division. She has been Chair of the Board of Directors at International School Basel Reinach AG.

Pascale Schmidt

Mr. Pascale Schmidt serves as Chief Compliance Officer of the Company.

Claudia Boeckstiegel

Ms. Claudia Boeckstiegel has been appointed as Member of the Corporate Executive Committee, General Counsel of the Company effective 4/1/2020. Claudia Boeckstiegel has been appointed as Member of the Corporate Executive Committee, General Counsel of the Company effective 4/1/2020. Ms. Claudia Böckstiegel is currently Head of Legal of the Diagnostics Division.

William Anderson

Mr. William N. (Bill) Anderson has been Member of the Corporate Executive Committee, Chief Executive Officer Roche Pharmaceuticals at Roche Holding Ltd since January 1, 2019. He is former Chief Executive Officer of Genentech.

William Pao

Dr. William Pao has been Member of the Enlarged Corporate Executive Committee, Head Roche Pharma Research & Early Development (pRED) at Roche Holding Ltd since April 2, 2018. He is former Global Head of the Oncology Discovery and Translational Area for pRED.

James Sabry

Dr. James H. Sabry, M.D., Ph.D., has been Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering at Roche Holding Ltd since August 1, 2018. He is former global Head Genentech Partnering.

Barbara Schaedler

Ms. Barbara Schaedler has been appointed as Member of the Enlarged Corporate Executive Committee, Head Group Communications of the Company effective 1 October 2019. Barbara Schädler's previous career as communications manager included positions at E.ON SE, Lufthansa, SAP and the German Federal Ministry of Finance. She holds a Master's degree in Economics from the Johannes Gutenberg University of Mainz.

Thomas Schinecker

Mr. Thomas Schinecker has been appointed as Member of the Corporate Executive Committee, Chief Executive Officer Roche Diagnostics of the Company with effect from 1 August 2019. He began his career in 2003 as a trainee for Roche Diagnostics under the Roche Perspectives programme. He has held various management positions in marketing & sales and product development in Singapore, Austria, Sweden and the United States. Before assuming his current position as Head of the Global Business Area Centralised and Point of Care Solutions based in Rotkreuz, Switzerland, he was General Manager for Roche Diagnostics Germany. Thomas Schinecker holds a PhD in Molecular Biology from New York University, USA.

Michael Varney

Dr. Michael David Varney, Ph.D., has been Member of the Enlarged Corporate Executive Committee, Head Genentech Research & Early Development (gRED) at Roche Holding Ltd since 2015. He holds Bachelor of Science degree form University of California, Los Angeles (Chemistry, 1980) and a Ph.D. from California Institute of Technology (Organic Synthesis, 1985). From 1985 to 1987 he was Postdoctoral Research Fellow at the Columbia University. In 1987 he joined Agouron Pharmaceuticals Inc., where he served until 2000 and held such positions as Research Chemist, Director Medicinal Chemistry, Senior Director of Chemistry, Senior Director of Drug Discovery, Vice President and Head of Research as well as US, Corporate Vice President, Head of Research. From 2000 to 2005 he served at Pfizer Global R&D as Vice President, Drug Discovery. In 2005 he joined Genentech Inc., where he acted as Vice President of Small Molecule Drug Discovery, Senior Vice President, Research of Small Molecule Drug Discovery and Senior Vice President, Co-Head of Research and Head Small Molecule Discovery.

Per-Olof Attinger

Mr. Per-Olof Attinger has been Secretary to the Corporate Executive Committee at Roche Holding Ltd since August 1, 2010. Mr. Attinger started his professional career in 1986 at Sandoz as Engineer responsible for Chemical Process Development. He has served at Roche since 1992, where he has occupied various managerial positons, including Manager of Mergers & Acquisitions, among others. In 1984, he obtained a degree in Chemical Engineering from the Federal Institute of Technology (ETH) Zurich. He than made Thesis at Imperial College in London and received his Masters degree in Busines Administration from European Institute for Business Administration (INSEAD) in 1992.

Hans Clevers

Prof. Dr. Hans Clevers serves as Director of the Company. He has been Member of the Scientific Advisory Board of Swiss Institute for Experimental Cancer Research (ISREC), Lausanne, CH, President of the International Society of Differentiation (ISD), Member of the board of the American Association for Cancer Research, Chief Scientific Officer der HUB Organoids Technology, Utrecht, NL.

Joerg Duschmale

Mr. Joerg Duschmale serves as Director of the Company. Since 2015-2018 Roche Postdoctoral Researcher in oligonucleotide chemistry, F. Hoffmann-La Roche, Basel, Switzerland (with Dr. K. Bleicher, Roche, Basel and Prof. Dr. J. Wengel, University of Southern Denmark, Odense, Denmark).

Patrick Frost

Dr. Patrick Frost serves as Director of the Company. He has been Member of the Board Swiss American Chamber of Commerce, Member of the Board Zurich Chamber of Commerce, Member of the Board, Vice President Zuercher Volkswirtschaftliche Gesellschaft.

Julie Brown

Ms. Julie Brown serves as Non-Executive Independent Director of the Company. She is Chairman of the Audit Committee at the Company.

Paul Bulcke

Mr. Paul Bulcke serves as Non-Executive Independent Director of the Company. He is Member of the Audit Committee at the Company. He started his career in 1977 as Financial Analyst with Scott Graphics International. In 1979 he joined Nestle Group where he held several position including Marketing trainee, sales and division functions, Market Head at Nestle Portugal, Nestle Chech and Slovak Republic, as well as at Nestle Germany. Between 2004 and 2008, Mr. Bulcke acted as Executive Vice President, Nestle S.A. as well as Zone Director for Zone Americas: United States of America, Canada, Latin America and Caribbean. Mr. Bulcke has been Chief Executive Officer of Nestle S.A. since April 2008. He studied Commercial Engineering at Katholieke Universiteit Leuven, from which he graduated in 1976. Between 1976 and 1977 he attended postgraduate studies in Management at Vlerick Leuven Gent Management School (Universiteit Gent), and in 1995 he completed Program for Executive Development at Institute of Management Development (IMD) Switzerland.

Anita Hauser

Ms. Anita Hauser serves as Non-Executive Independent Director of the Company. She is Member of the Corporate Governance and Sustainability Committee at the Company.

Richard Lifton

Prof. Dr. Richard P. Lifton serves as Non-Executive Independent Director of the Company. He is Member of the Remuneration Committee at the Company.

Bernard Poussot

Mr. Bernard J. Poussot serves as Non-Executive Independent Director of the Company. He is Member of the Remuneration Committee at the Company.

Claudia Suessmuth Dyckerhoff

Dr. Claudia Suessmuth Dyckerhoff serves as Non-Executive Independent Director of the Company. She is Member of the Corporate Governance and Sustainability Committee and the Audit Committee at the Company.

Karl Mahler